|
Volumn 8, Issue 6, 2013, Pages 623-625
|
Is irisin an early marker of statin-induced myopathy? Bench to the bedside
|
Author keywords
ezetimibe; irisin; lipid metabolism; simvastatin; skeletal muscle cell
|
Indexed keywords
CHOLESTEROL;
EZETIMIBE;
FIBRONECTIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
IRISIN;
LIPOPROTEIN A;
LOW DENSITY LIPOPROTEIN RECEPTOR;
SIMVASTATIN;
UBIDECARENONE;
UNCLASSIFIED DRUG;
APOPTOSIS;
ARTICLE;
CELL VIABILITY;
DISEASE MARKER;
FNDC5 GENE;
GENE;
HUMAN;
MYOPATHY;
OXIDATIVE STRESS;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
PROTEIN EXPRESSION;
SKELETAL MUSCLE;
|
EID: 84889587952
PISSN: 17584299
EISSN: 17584302
Source Type: Journal
DOI: 10.2217/clp.13.71 Document Type: Article |
Times cited : (3)
|
References (7)
|